AI assistant
NEOGENOMICS INC — Director's Dealing 2022
Sep 8, 2022
32227_dirs_2022-09-07_4995481e-7371-4b15-aa07-d52d6fb8a880.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3/A — Form 3/A
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2022-07-07
Reporting Person: Kulkarni Shashikant (President of Lab Operations)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 61728 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $12.15 | 2029-04-01 | Common Stock (132744.0) | Direct |
Footnotes
F1: This Amended Form 3 reflects an additional 20,576 restricted stock awards granted on April 1, 2022 that were omitted due to administrative error on the original Form 3 filed on July 15, 2022 and the subsequent Form 4 filed on August 3, 2022.
F2: On April 1, 2022, Dr. Kulkarni was granted 132,744 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F3: This Amended Form 3 reflects an additional 44,248 stock options granted on April 1, 2022 that were omitted due to administrative error on the original Form 3 filed on July 15, 2022 and the subsequent Form 4 filed on August 3, 2022.